Summer Update

Course Directors

Harry R. Hill, MD
Larry G. Reimer, MD
Judy A. Daly, PhD,
Kimberly E. Hanson, MD
David R. Hillyard, MD
Julio C. Delgado, MD, MS

Sponsored by:

The University of Utah School of Medicine
The Department of Pathology Division of Clinical Pathology

with the promotional support of:
ARUP Laboratories
Laboratories of Immunology & Infectious Diseases


This 24.25 hour review and update in the areas of clinical immunology, microbiology, and infectious diseases is intended to improve knowledge about the pathogenesis and clinical manifestations of infectious diseases, immunological mechanisms of disease and disease prevention, appropriate approaches to the diagnosis of infections and immunologic disorders, and utilization of the clinical microbiology and immunology laboratory including test selection and interpretation of results.

This course will provide a forum for the exchange of ideas dealing with microbial infections as well as immunity to infectious diseases and immunologic disorders. Faculty consists of clinicians involved in patient care, pathologists, and clinical laboratory scientists.  Discussion of timely topics by faculty and participants assures that this course will be informative, interesting, and relevant.

On completion of the course, attendees should be able to:

  • Identify new emerging pathogens, infectious syndromes, and immunologic diseases including clinical presentations
  • Critically analyze current practice and laboratory procedures in diagnosing infectious and immunologic disorders as well as result reporting
  • Update the current knowledge of the epidemiology and mechanisms of transmission of infectious disorders and the use of serologic testing in such studies
  • Assess new therapeutic modalities, which are being developed or utilized in treating infectious and immunologic diseases
  • Discuss molecular diagnoses of infections and immunologic disorders

Who Should Attend

Pathologists, clinical pathologists, laboratory scientists, pediatric, medicine and family medicine clinicians, infectious disease specialists, clinical immunologists and allergists, microbiologists, residents and postdoctoral fellows. Medical technologists, laboratory managers, nurse practitioners, hospital epidemiologists, research and development technologists. Pharmaceutical and diagnostic industry personnel will also find the course of great value (suggested background: professional degrees or medical technologist degrees in pathology, microbiology, immunology and infectious diseases.

Special Topics

  • FDA Intent to Regulate Laboratory Developed Tests
  • Using Fetal Cell Free DNA to Test for Primary Immune Deficiencies
  • Typhoid (Enteric Fever) in Uganda (a persistent and terrible disease)
  • Predominance of Virally Induced Cancers in African Settings (a big difference from Europe or North America)
  • Six Decades on the Gridiron of Microbes versus Hosts
  • The Changing Faces of Staphylococci
  • StrepTSS, Necrotizing faciitis, GAS in General
  • Cardiomyopathy in Bacterial Infections
  • Host Gene Expression for Diagnosis of Infectious Diseases
  • Targeted Virus Capture to Enhance the Sensitivity of Metagenomic Shotgun Sequencing
  • Laboratory Diagnosis of Sepsis and Cerebrospinal Infections
  • Informing the Front Line of Infectious Agent Circulation
  • Laboratory Assessment of Monoclonal Antibody Therapeutics
  • Use of Free Light and Heavy Chain testing for Plasma Cell Dyscrasias and Beyond
  • Advanced MALDI-TOF for Microbiology
  • Next Generation Strain Typing
  • The Potential Impact of New Diagnostics for Optimal Antimicrobial Use
  • Practical use of Current Fungal Diagnostics
  • Staying Safe in the Tetons
  • Significance of Lowered Immunoglobulins
  • Strep Pneumonia Antibody “Controversy”
  • Hepatitis – New Developments
  • Microbiomes in Health and Disease
  • HIV 2016
  • Case Presentations
  • Orofacial Infections
  • Unbiased Pathogen Detection by Next Generation Sequencing in a Diagnostic Laboratory
  • HPV – Women’s Health Issues
  • Diagnostic Trends in Laboratory Evaluation of Antiphospholipid Syndrome
  • Autoantibodies in Inflammatory Myopathy